Inicio
Resultado de la búsqueda
1 búsqueda de la palabra clave 'nephrocalcinosis'
Clasificado(s) por (Año de edición descendente) Refinar búsqueda Genera el flujo rss de la búsqueda
Enlace permanente de la investigación
Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review / John Fredy Nieto Ríos ; Catalina Ocampo Kohn ; Gustavo Adolfo Zuluaga Valencia ; Arbey Aristizabal Álzate
Título : Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Gustavo Adolfo Zuluaga Valencia, ; Arbey Aristizabal Álzate, Fecha de publicación : 2017 Títulos uniformes : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Hyperoxaluria primary kidney failure chronic kidney transplantation lithiasis nephrocalcinosis Resumen : Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, nephrocalcinosis and end stage renal disease (ESRD). In patients with ESRD that receive kidney transplantation alone, the disease has a relapse of 100%, with graft loss in a high percentage of patients in the first 5 years of transplantation. Three molecular disorders have been described in PH: mutation of the gene alanin glioxalate aminotransferase (AGXT); glyoxalate reductase/hydroxy pyruvate reductase (GRHPR) and 4-OH-2-oxoglutarate aldolase (HOGA1). We present two cases of patients with a history of renal lithiasis who were diagnosed with primary hyperoxaluria in the post-transplant period, manifested by early graft failure, with evidence of calcium oxalate crystals in renal biopsy, hyperoxaluria, hyperoxalemia, and genetic test compatible; they were managed with proper diet, abundant oral liquids, pyridoxine, hydrochlorothiazide and potassium citrate; however, they had slow but progressive deterioration of their grafts function until they reached end-stage chronic renal disease. Mención de responsabilidad : John Fredy Nieto Rios, Monica Zuluaga, Lina Maria Serna Higuita, Adriana Florez, Diana Carolina Bello-Marquez, Arbey Aristizábal, Catalina Ocampo Kohn, Gustavo Adolfo Zuluaga Referencia : J Bras Nefrol. 2017 Oct-Dec;39(4):462-466. DOI (Digital Object Identifier) : 10.5935/0101-2800.20170081 PMID : 29319775 Derechos de uso : CC BY En línea : http://bjn.org.br/about-the-authors/1996/en-US Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4072 Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review [documento electrónico] / John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Gustavo Adolfo Zuluaga Valencia, ; Arbey Aristizabal Álzate, . - 2017.
Obra : Brazilian Journal of Nephrology
Idioma : Inglés (eng)
Palabras clave : Hyperoxaluria primary kidney failure chronic kidney transplantation lithiasis nephrocalcinosis Resumen : Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, nephrocalcinosis and end stage renal disease (ESRD). In patients with ESRD that receive kidney transplantation alone, the disease has a relapse of 100%, with graft loss in a high percentage of patients in the first 5 years of transplantation. Three molecular disorders have been described in PH: mutation of the gene alanin glioxalate aminotransferase (AGXT); glyoxalate reductase/hydroxy pyruvate reductase (GRHPR) and 4-OH-2-oxoglutarate aldolase (HOGA1). We present two cases of patients with a history of renal lithiasis who were diagnosed with primary hyperoxaluria in the post-transplant period, manifested by early graft failure, with evidence of calcium oxalate crystals in renal biopsy, hyperoxaluria, hyperoxalemia, and genetic test compatible; they were managed with proper diet, abundant oral liquids, pyridoxine, hydrochlorothiazide and potassium citrate; however, they had slow but progressive deterioration of their grafts function until they reached end-stage chronic renal disease. Mención de responsabilidad : John Fredy Nieto Rios, Monica Zuluaga, Lina Maria Serna Higuita, Adriana Florez, Diana Carolina Bello-Marquez, Arbey Aristizábal, Catalina Ocampo Kohn, Gustavo Adolfo Zuluaga Referencia : J Bras Nefrol. 2017 Oct-Dec;39(4):462-466. DOI (Digital Object Identifier) : 10.5935/0101-2800.20170081 PMID : 29319775 Derechos de uso : CC BY En línea : http://bjn.org.br/about-the-authors/1996/en-US Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4072 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000676 AC-2017-065 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2017-065.pdfAdobe Acrobat PDF